Study about correlation of anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies with thromboangiitis obliterans

被引:12
|
作者
Guo, Yi [1 ]
Dai, Yuanbin [1 ]
Lai, Junyu [2 ]
Fan, Ying [3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, Chongqing 400016, Peoples R China
[2] People Hosp Luzhou, Dept Gen Surg, Luzhou, Peoples R China
[3] Second People Hosp Yibin, Dept Gen Surg, Yibin, Sichuan, Peoples R China
关键词
Anti-neutrophil cytoplasmic antibodies (ANCA); anticardiolipid antibodies (ACA); thromboangiitis obliterans (TAO); THROMBOSIS; DISEASE; PATHOGENESIS; RISK; ANCA;
D O I
10.1177/1708538113478742
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Doctors often have difficulties in clinical diagnosis and clinical stage of thromboangiitis obliterans (TAO). Immunolesion was important in the initiation and progression of various kinds of vasculitis diseases, including TAO. Several kinds of immune complexes were developed by immunolesion, including anti-neutrophil cytoplasmic antibodies (ANCA) and anticardiolipin antibodies (ACA). Our aim was to determine if it is an effective way for clinical diagnosis and clinical stage of TAO by detection of the presence of ANCA and ACA in blood serum of patients with TAO and the relationship among the presence of ANCA, ACA and patients with different grades of TAO. Blood samples and clinical characteristics were collected from 38 patients with Rutherford grade I TAO, 30 patients with Rutherford grade II-III TAO, 75 patients with arteriosclerosis obliterans (ASO) and 65 healthy volunteers. Their serum samples were investigated for ANCA by indirect immunofluorescent (IIF), and for ACA and ANCA specificity antigens including reactivity to proteinase 3(PR3), myeloperoxidase (MPO), cathepsin G (CG), bactericidal/permesbility-increasing protein (BPI), elastase (HLE) and lactoferrin (LF) by enzyme linked immunosorbent assay (ELISA). (1) ANCA positive rate and titre were much higher in cases with Rutherford grade I TAO (52.6%, 20/38, 0.386 +/- 0.458) and Rutherford grade II-III TAO (73.3%, 22/30, 0.847 +/- 0.658) than those in cases with ASO (4%, 3/75, 0.011 +/- 0.002) and healthy volunteers (0%,0/65, 0.010 +/- 0.002) (P < 0.01). ANCA positive rate and titre were higher in cases with Rutherford grade II-III TAO (73.3%, 22/30, 0.847 +/- 0.658) than those in cases with Rutherford grade I TAO (52.6%, 20/38, 0.386 +/- 0.458) (P < 0.05). (2) ACA concentration was much higher in cases with Rutherford grade I TAO (270.13 +/- 13.05 IU/mL) and Rutherford grade II-III TAO (279.33 +/- 19.98 IU/mL) than that in cases with ASO (236.85 +/- 17.32 IU/mL) and healthy volunteers (229.16 +/- 15.55 IU/mL) (P < 0.05) respectively. (3) In 42 cases of ANCA-positive samples, there were 20 cases reacted with MPO, 14 cases reacted with LF, five cases reacted with HLE, five cases reacted with BPI and no one reacted with PR3 and CG. All cases were Rutherford grade II-III TAO. Our results indicate that ANCA, ANCA specificity antigens and ACA were detected susceptibly and availably in patients with TAO. Thus, detection of ANCA, ANCA specificity antigens and ACA was helpful for clinical diagnosis of TAO and detection of ANCA and ANCA specificity antigens was helpful for clinical staging of TAO. They are important assistance for clinical diagnosis and stage of TAO.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 50 条
  • [21] Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and literature review
    Zhang, Jun
    Zhang, Heng-Yuan
    Chen, Shi-Zhi
    Huang, Ji-Yi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (02) : 1012 - 1018
  • [22] The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)
    Weiner, Maria
    Segelmark, Marten
    AUTOIMMUNITY REVIEWS, 2016, 15 (10) : 978 - 982
  • [23] Neutrophil fixation protocols suitable for substrates to detect anti-neutrophil cytoplasmic antibodies by indirect immunofluorescence
    Nishibata, Yuka
    Matsuzawa, Shun
    Satomura, Yosuke
    Ohtsuka, Takeshi
    Kuhara, Motoki
    Masuda, Sakiko
    Tomaru, Utano
    Ishizu, Akihiro
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 228
  • [24] Systemic Vasculitis Associated with Anti-Neutrophil Cytoplasmic Antibodies against Bactericidal/Permeability Increasing Protein
    Fukuhara, Atsuro
    Tanino, Yoshinori
    Sato, Suguru
    Ishii, Taeko
    Nikaido, Takefumi
    Kanazawa, Kenya
    Saito, Junpei
    Ishida, Takashi
    Kanno, Makoto
    Watanabe, Tsuyoshi
    Munakata, Mitsuru
    INTERNAL MEDICINE, 2013, 52 (10) : 1095 - 1099
  • [25] Anti-neutrophil cytoplasmic antibodies tests: Which tests should be used in practice?
    Wiik, A
    INTERNAL MEDICINE, 2001, 40 (06) : 466 - 470
  • [26] An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice
    Damoiseaux, Jan
    Heijnen, Ingmar
    Van Campenhout, Christel
    Eriksson, Catharina
    Fabien, Nicole
    Herold, Manfred
    van der Molen, Renate G.
    Egner, William
    Patel, Dina
    Plaza-Lopez, Aresio
    Radice, Antonella
    Rego de Sousa, Marie Jose
    Viander, Markku
    Shoenfeld, Yehuda
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (10) : 1759 - 1770
  • [27] Anti-neutrophil antibodies in primary sclerosing cholangitis
    Terjung, B
    Worman, HJ
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2001, 15 (04) : 629 - 642
  • [28] Epitope-specific anti-neutrophil cytoplasmic antibodies: Do they matter? Can they be detected?
    Specks, Ulrich
    APMIS, 2009, 117 : 63 - 66
  • [29] A Case Report of Anti-Neutrophil Cytoplasmic Antibodies Negative Churg-Strauss Syndrome
    Lee, Seung Beom
    Kang, Hee Cheol
    Choi, Jun Jeong
    KOREAN JOURNAL OF FAMILY MEDICINE, 2010, 31 (04): : 308 - 313
  • [30] Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies
    Watanabe, Hitoshi
    Kitagawa, Wataru
    Suzuki, Keisuke
    Yoshino, Masabumi
    Aoyama, Ryuhei
    Miura, Naoto
    Nishikawa, Kazuhiro
    Imai, Hirokazu
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (06) : 598 - 601